Novel prodrugs of decitabine with greater metabolic stability and less toxicity.

MLA

Hattori, Naoko, et al. “Novel Prodrugs of Decitabine with Greater Metabolic Stability and Less Toxicity.” Clinical Epigenetics, vol. 11, no. 1, Aug. 2019, p. 111. EBSCOhost, https://doi.org/10.1186/s13148-019-0709-y.

APA

Hattori, N., Sako, M., Kimura, K., Iida, N., Takeshima, H., Nakata, Y., Kono, Y., & Ushijima, T. (2019). Novel prodrugs of decitabine with greater metabolic stability and less toxicity. Clinical Epigenetics, 11(1), 111. https://doi.org/10.1186/s13148-019-0709-y

Chicago

Hattori, Naoko, Magoichi Sako, Kana Kimura, Naoko Iida, Hideyuki Takeshima, Yoshitaka Nakata, Yutaka Kono, and Toshikazu Ushijima. 2019. “Novel Prodrugs of Decitabine with Greater Metabolic Stability and Less Toxicity.” Clinical Epigenetics 11 (1): 111. doi:10.1186/s13148-019-0709-y.